
Esketamine is a breakthrough option for treatment-resistant depression. Significant benefits have been seen in improving mood and alleviating depressive symptoms when used in conjunction with oral antidepressants. This innovative treatment is administered under the supervision of a healthcare professional and has shown promise in rapidly reducing depressive symptoms. We see this treatment as offering hope for those who have not responded to multiple standard antidepressant medications.